Inactive Instrument

Insiders Concert Pharmaceuticals, Inc.

Equities

CNCE

US2060221056

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Insider Sell: Concert Pharmaceuticals	23-01-31	MT
Insider Buy: Concert Pharmaceuticals	22-06-06	MT
Concert Pharmaceuticals, Inc. Announces Not Stand for Re-Election of Ronald W. Barrett as Independent Director	22-02-03	CI
Concert Pharmaceuticals, Inc. Announces Executive Changes	19-10-30	CI
Concert Pharmaceuticals Names Jeffrey Munsie as Chief Legal Officer	19-09-23	CI
Concert Pharmaceuticals, Inc. Appoints Jesper Høiland to Board of Directors and as Member of its Compensation Committee	19-04-29	CI
Concert Pharmaceuticals, Inc. Notifies Meghan Fitzgerald's Decision to Resign as a Member of the Board	18-12-17	CI
Concert Pharmaceuticals, Inc. Announces Appointment of Marc Becker as Chief Financial Officer, Effective January 4, 2018	17-12-18	CI
Concert Pharmaceuticals, Inc. Appoints Ryan Lynch as the Principal Financial Officer and Principal Accounting Officer	17-06-19	CI
Concert Pharmaceuticals, Inc. Announces Executive Changes	17-05-25	CI
Concert Pharmaceuticals, Inc. Appoints Ryan Daws as Principal Accounting Officer	16-09-16	CI
Concert Pharmaceuticals, Inc. Announces Resignation of Pauline Mcgowan as Vice President, Finance, Corporate Controller and Treasurer	16-09-06	CI
Concert Pharmaceuticals Announces Executive Changes	16-09-06	CI
Concert Pharmaceuticals, Inc. Announces Board Changes	16-04-14	CI
Concert Pharmaceuticals, Inc. Appoints Meghan FitzGerald to its Board of Directors	16-03-23	CI
Concert Pharmaceuticals, Inc. Announces Resignation of John G. Freund as Member of the Board of Directors	15-04-10	CI
Concert Pharmaceuticals, Inc. Appoints James V. Cassella as Chief Development Officer	15-02-04	CI
Concert Pharmaceuticals Appoints Thomas G. Auchincloss to the Board of Directors and Independent Chair of the Audit Committee	14-12-10	CI
Concert Pharmaceuticals, Inc. Appoints Wendell Wierenga to Board of Directors	14-03-14	CI
Concert Pharmaceuticals, Inc. Appoints Ryan Daws as Chief Financial Officer	14-01-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Concert Pharmaceuticals, Inc.

Equities

CNCE

US2060221056

Insiders

Filters